Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol

Evolution of the Cancer Stem Cell Model

(2014) Antonija Kreso et al.   Cell Stem Cell

Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity

(2013) Rebecca Lamb et al.   CELL CYCLE

Notch Signaling–related Therapeutic Strategies With Novel Drugs in Neuroblastoma Spheroids

(2013) Sule Ayla et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Tumour heterogeneity and cancer cell plasticity

(2013) Corbin E. Meacham et al.   NATURE

Acute Myeloid Leukaemia

(2011) Luis Villela et al.   DRUGS

Flavopiridol inducesBCL-2expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia

(2011) Dwella M. Nelson et al.   LEUKEMIA & LYMPHOMA

Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen

(2010) Velasco Cimica et al.   BMC CANCER

Retinoblastoma Tumor Suppressor Gene Expression Determines the Response to Sequential Flavopiridol and Doxorubicin Treatment in Small-Cell Lung Carcinoma

(2009) T. Budak-Alpdogan et al.   CLINICAL CANCER RESEARCH

Mechanism of Drug Sensitivity and Resistance in Melanoma

(2009) Caterina La Porta   CURRENT CANCER DRUG TARGETS

Rhabdoid Tumor Growth is Inhibited by Flavopiridol

(2008) M. E. Smith et al.   CLINICAL CANCER RESEARCH